Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
1 - 10 employees
Stage
Seed
founded in
2020
Modulus Therapeutics is a pioneering company focused on developing optimized cell therapies for autoimmune diseases. By leveraging the safety profile of Natural Killer (NK) cells and innovative engineering techniques, they aim to create off-the-shelf CAR-NK therapies that enhance patient access and safety. Their approach addresses significant limitations of existing CAR-T therapies, such as patient selection dilemmas and accessibility issues, by eliminating the need for lymphodepletion and offering tailored potency through advanced receptor designs. With a commitment to rapid prototyping and generative design, Modulus is positioned to lead in the cell therapy market, providing effective solutions for underserved autoimmune patients.
Something looks off?